Adrian Thomas serves as, Vice President Global Public Health, at Johnson & Johnson. He is responsible for global public health programs and strategy addressing Global Health Security threats and pandemic preparedness including antimicrobial resistance (AMR), Multi Drug Resistant Tuberculosis (MDRTB), Ebola, Dengue Fever, HIV vaccines amongst others. Adrian is a physician with a special interest in the fields of disease area strategy, public health, market access, and pharmaceutical policy. He has held numerous roles in market access including Global Head of Market Access for Janssen & Global Head of Access for Medical Devices, for Johnson & Johnson, as well as roles in risk management and drug safety, including Global Head of Benefit Risk Management and Chief Safety Officer for Janssen.
Prior to joining J&J, Adrian held roles in regional medical affairs, drug development and product management for Schering-Plough and Eli Lilly. He is a clinical pharmacologist and a vascular physician with experience in clinical trials design and methodology.
Adrian is a Fellow of the Royal Australasian College of Physicians and the College of Medial Administrator’s. He received his Bachelor of Medicine and Bachelor of Surgery degrees from the University of Melbourne in Australia.
He is based in New Hope, PA.
